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ABSTRACT: The development of eﬃcient methods for the
generation of enantioenriched sulfonamides and sulfones is an
important objective for ﬁelds such as organic synthesis and
medicinal chemistry; however, there have been relatively few
reports of direct catalytic asymmetric approaches to controlling
the stereochemistry of the sulfur-bearing carbon of such
targets. In this report, we describe nickel-catalyzed stereo-
convergent Negishi arylations and alkenylations of racemic α-bromosulfonamides and -sulfones that furnish the desired cross-
coupling product in very good ee and yield for an array of reaction partners. Mechanistic studies are consistent with the
generation of a radical intermediate that has a suﬃcient lifetime to diﬀuse out of the solvent cage and to cyclize onto a pendant
oleﬁn.
■ INTRODUCTION
Sulfonamides and sulfones serve both as useful intermediates in
organic synthesis1 and as important target molecules in their
own right.2,3 For example, enantioenriched secondary benzylic
sulfonamides and sulfones display a range of biological activity
(e.g., protein tyrosine phosphatase inhibitor,4 antisepsis agent,5
and γ-secretase inhibitor6).7 However, to the best of our
knowledge, there are no methods for the direct catalytic
asymmetric synthesis of such sulfonamides, and just a few for
such sulfones.8
One potential route to these compounds is the stereo-
convergent coupling of a racemic α-halosulfonamide/sulfone
with an appropriate nucleophile (eq 1). During the past several
years, we have described an array of nickel-catalyzed
enantioselective cross-couplings of secondary alkyl electro-
philes. Whereas couplings of activated electrophiles (a leaving
group α to a carbonyl, aryl, alkenyl, alkynyl, or cyano group)
proceed in good ee with a variety of nucleophiles (alkyl-, aryl-,
and alkenylmetal),9,10 reactions of unactivated electrophiles
have been limited, with three exceptions,11 to alkylmetals,
speciﬁcally alkyl-(9-BBN) reagents.12
Because α-halosulfonyl compounds are generally poor
substrates for SN2 reactions, and the sulfonyl group does not
eﬀectively stabilize an adjacent radical (bond dissociation
energy for a C−H bond of dimethylsulfone: 99 kcal/mol),13
we view them as unactivated alkyl electrophiles. Herein, we
report the ﬁrst examples of the stereoconvergent cross-coupling
of unactivated alkyl electrophiles with nucleophiles other than
organoboranes, as well as the ﬁrst general method for their
coupling with aryl- or alkenylmetal reagents; in particular, we
describe nickel/bis(oxazoline)-catalyzed cross-couplings of
racemic α-bromosulfonamides and -sulfones with organozinc
and organozirconium reagents, thereby furnishing secondary
benzylic and allylic sulfonamides and sulfones in good
enantiomeric excess (eq 2).14
■ RESULTS AND DISCUSSION
Upon investigating a variety of reaction parameters, we
determined that a nickel/bis(oxazoline)15 catalyst can achieve
the cross-coupling of an α-bromosulfonamide with an arylzinc
reagent in very good ee and yield at −20 °C (Table 1, entry 1);
NiCl2·glyme and bis(oxazoline) L1 ((R,R) and (S,S)) are
commercially available. All previous reports of stereoconvergent
Negishi reactions of racemic electrophiles have employed
activated coupling partners.9a−c,e−g
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Essentially no cross-coupling is observed in the absence of
NiCl2·glyme (Table 1, entry 2), and a low yield of the desired
product is obtained if ligand L1 is omitted (entry 3). At room
temperature, the coupling proceeds in good ee, but hydro-
debromination predominates over C−C bond formation. The
corresponding valine-derived bis(oxazoline) (L2) is nearly as
eﬀective as phenylglycine-derived L1 (entries 1 and 5), whereas
removal of the gem-dimethyl substituents on the linker
between the oxazolines of L1 leads to a substantial drop in
eﬃciency (entry 6). Although pybox ligands are often the
ligand of choice for nickel-catalyzed stereoconvergent Negishi
reactions,9a−c,e pybox L4 is not eﬀective for this particular
cross-coupling, nor is a 1,2-diamine ligand9d,12 (entries 7 and
8). The use of PhMgBr in place of PhZnI leads to a small loss
in ee and a substantial loss in yield (entry 9). When the catalyst
loading is reduced in half, no erosion in enantioselectivity is
observed, although the yield falls by a modest amount (entry
10). The process is somewhat oxygen-sensitive (entry 11; 66%
conversion) but not particularly moisture-sensitive (entry 12).
Under these conditions, we can achieve stereoconvergent
Negishi cross-couplings of a variety of racemic α-bromosulfon-
amides with PhZnI to generate highly enantioenriched benzylic
sulfonamides (Table 2).16 The nitrogen of the sulfonamide can
bear either an alkyl or an aryl substituent, with little impact on
ee or yield (entries 1−5). Furthermore, the R1 side chain can
include functional groups and can be either primary (entries 6−
8) or secondary (entry 9), although in the case of the latter a
diminished yield is observed. On a gram scale, the cross-
coupling illustrated in entry 2 proceeds in 92% ee and 98%
yield.
The conditions that we developed for stereoconvergent
Negishi reactions of α-bromosulfonamides (Table 2) can be
applied without modiﬁcation to the corresponding sulfones
(Table 3).17 The scope with respect to the sulfone is broad.
Thus, the R substituent can range in steric demand from methyl
to t-butyl (entries 1−4), and it can be aromatic (entry 5). With
respect to the R1 group, it may be linear or branched (entries
1−5).
Table 1. Stereoconvergent Negishi Phenylation of a Racemic
α-Bromosulfonamide: Eﬀect of Reaction Parametersa
entry change from the “standard conditions” ee (%) yield (%)b
1 none 96 88
2 no NiCl2·glyme − <2
3 no L1 − 16
4 r.t., instead of −20 °C 93 39
5 L2, instead of L1 93 84
6 L3, instead of L1 78 28
7 L4, instead of L1 56 6
8 L5, instead of L1 70 44
9 PhMgBr, instead of PhZnI 89 44
10 5% NiCl2·glyme, 6.5% L1 96 72
11 under air, rather than under N2 (capped vial) 96 52
12 0.1 equiv of water added 97 84
aAll data are the average of two experiments. bThe yield was
determined through GC analysis with the aid of a calibrated internal
standard.
Table 2. Stereoconvergent Negishi Phenylations of Racemic
α-Bromosulfonamides: Scope with Respect to the
Sulfonamidea
aAll data are the average of two experiments. bYield of puriﬁed
product. cAmount of PhZnI: 1.5 equiv.
Table 3. Stereoconvergent Negishi Phenylations of Racemic
α-Bromosulfones: Scope with Respect to the Sulfonea
aAll data are the average of two experiments. bYield of puriﬁed
product. cAmount of PhZnI: 1.5 equiv.
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We have examined the scope of arylzinc nucleophiles that
participate in this method for the catalytic asymmetric synthesis
of benzylic sulfonamides and sulfones (Table 4). Electron-rich
and electron-poor arylzinc reagents are suitable partners, as is a
heteroarylzinc reagent, furnishing the desired product in very
good ee. Especially noteworthy is our observation that o-
substituted phenylzinc reagents can be employed with both
sulfonamide- and sulfone-based electrophiles (entries 5−7 and
9−11); in our previous studies of nickel-catalyzed enantiose-
lective arylations, o-substituted nucleophiles have generally
been poor coupling partners.18,19
Next, we sought to expand the scope of stereoconvergent
cross-couplings of α-bromosulfonamides and -sulfones to
include a second family of nucleophiles, speciﬁcally, alkenyl-
metal reagents. We determined that, whereas reactions of
alkenylzinc reagents proceed in poor yield using the method
described above, alkenylzirconium reagents serve as suitable
nucleophiles under modiﬁed conditions (Table 5).20,21 Thus,
an array of allylic sulfonamides and sulfones22 can be
synthesized with good enantioselectivity in the presence of
functional groups such as a thiophene and a primary alkyl
chloride.
We have suggested that, for at least some nickel-catalyzed
cross-couplings of alkyl electrophiles, an alkyl radical may be
generated during the oxidative-addition step of the catalytic
cycle.23,24 In the case of electrophiles that bear an appropriately
positioned pendant oleﬁn, we have observed complete
cyclization of the putative radical onto the oleﬁn in some
instances,25 and no cyclization in another.9f
In order to gain insight into the mechanism of the
stereoconvergent arylations described herein, we investigated
the Negishi reaction of an α-bromosulfonamide bearing a
pendant oleﬁn (eq 3).26 At 70% conversion of the electrophile,
we observe a 38% yield of the direct (uncyclized) cross-
coupling product (8) and a 17% combined yield of cyclized
cross-coupling products (9).
Cyclopentane derivatives cis-9 and trans-9 are each an ∼1:1
mixture of diastereomers (diﬀering in the relative stereo-
chemistry at the deuterium-bearing carbon), consistent with the
expectation for cyclization of radical intermediate 10 (but not
for a simple organometallic pathway involving only β-migratory
insertion and then reductive elimination). Our observation that
uncyclized cross-coupling product 8 has deuterium only in the
trans position suggests that, when intermediate 10 does cyclize,
the process is irreversible.
Simple 5-hexenyl radical cyclizations proceed with ﬁrst-order
rate constants of ∼105 s−1.27 Although, to the best of our
knowledge, the rate of cyclization of sulfonamide-substituted
radical 10 has not been determined, it is very likely to be
signiﬁcantly slower than diﬀusion (∼109 s−1).13a Our
Table 4. Stereoconvergent Negishi Arylations of α-
Bromosulfonamides and -Sulfones: Scope with Respect to
the Arylzinc Reagenta
aAll data are the average of two experiments. bYield of puriﬁed
product. cAmount of ArZnI: 2.0 equiv; amount of catalyst: 20% NiCl2·
glyme, 26% (R,R)-L1.
Table 5. Stereoconvergent Negishi Cross-Couplings of α-
Bromosulfonamides and -Sulfones: Alkenylzirconium
Reagents as Nucleophilesa
aAll data are the average of two experiments. bYield of puriﬁed
product. cLigand used: (R,R)-L1.
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observation of cyclized, cross-coupled products (9) therefore
represents evidence that a nickel-catalyzed asymmetric cross-
coupling process may include a noncage radical pathway.
Consistent with this suggestion, the ratio of uncyclized (D)/
cyclized (C) product changes as the concentration of catalyst
changes (Figure 1).28
■ CONCLUSIONS
We have developed methods for the enantioselective synthesis
of secondary sulfonamides and sulfones, speciﬁcally, nickel-
catalyzed Negishi arylations and alkenylations of racemic α-
bromosulfonamides and -sulfones with readily available organo-
zinc and organozirconium reagents; with regard to stereo-
convergent couplings of unactivated alkyl electrophiles,
previous examples had been limited to organoboron
nucleophiles and, with the exception of three isolated examples,
to alkylation reactions. In terms of mechanism, a cyclization/
stereochemical probe has provided evidence for a radical
intermediate that has a suﬃcient lifetime to escape the solvent
cage and cyclize irreversibly under the coupling conditions.
Additional studies directed at elucidating the mechanisms of
cross-coupling reactions of alkyl electrophiles, as well as
expanding the scope of such processes, are underway.
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